mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.006 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.006 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.007 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.007 |